Vaccine manufacturing doesn’t come cheap. It depends heavily on support from developed countries. It also requires much more than relaxing intellectual property rights and a desire for vaccine equity.
Evolutionary medicine uses our ancestral history to explain disease prevalence and inform care for conditions like Type 2 diabetes. It also challenges the bio-ethnocentrism of western medicine.
Jaishree Raman, National Institute for Communicable Diseases et Shüné Oliver, National Institute for Communicable Diseases
Southern African Development Community countries are very connected. Highly mobile and migrant populations frequently cross borders, posing significant challenges to reaching a malaria-free region.
Jeremy Herren, International Centre of Insect Physiology and Ecology et Clifford Mutero, International Centre of Insect Physiology and Ecology
This invasive mosquito thrives in the type of habitat commonly found in urban areas. This means that malaria could become more prevalent in African cities.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
Malaria, tuberculosis and HIV/AIDS are regarded as the ‘big three’ infectious diseases. This is where scientists are at in their efforts to find a vaccine for each one.
A warming climate may change the types of viruses that thrive. A new report suggests that the threat of malaria may be replaced by dengue, for which there is no treatment and no cure.
Currently, there is no evidence that this highly effective antimalarial can treat COVID-19 – and the threat of drug resistance should deter us from using it indiscriminately.
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases